An overview of the cancer burden for primary care physicians
- PMID: 19616149
- DOI: 10.1016/j.pop.2009.04.001
An overview of the cancer burden for primary care physicians
Abstract
Primary care physicians and other caregivers are uniquely positioned to communicate with patients about their real risks of developing or dying from cancer and actions that can reduce these risks. This article discusses the statistics used to measure the cancer burden in a manner intended to help primary caregivers communicate more effectively with patients about cancer. The basic terms used to measure incidence, mortality, and relative survival, and considerations that influence the interpretation of cancer trends are described; opportunities to accelerate progress in reducing cancer incidence and death rates are identified. Although integrating effective prevention measures into standard clinical care will require changes in health care policy and in clinical practice, the combination of these approaches is essential to prevent the massive anticipated increase in the number of cancer cases, due to growth and aging of the population.
Similar articles
-
Cancer control in low- and middle-income countries: the role of primary care physicians.Prim Care. 2009 Sep;36(3):455-70. doi: 10.1016/j.pop.2009.04.008. Prim Care. 2009. PMID: 19616150
-
Cancer in the elderly: is it preventable?Clin Geriatr Med. 2004 May;20(2):293-316. doi: 10.1016/j.cger.2004.03.002. Clin Geriatr Med. 2004. PMID: 15182883 Review.
-
Cancer in the elderly: a societal perspective from the United States.Clin Oncol (R Coll Radiol). 2009 Mar;21(2):92-8. doi: 10.1016/j.clon.2008.11.008. Epub 2008 Dec 6. Clin Oncol (R Coll Radiol). 2009. PMID: 19059768
-
Making progress against cancer in Europe in 2008.Eur J Cancer. 2008 Jul;44(10):1451-6. doi: 10.1016/j.ejca.2008.02.015. Epub 2008 Mar 18. Eur J Cancer. 2008. PMID: 18353629
-
Disparities, cancer surveillance, and next steps.J Cancer Educ. 2006 Spring;21(1 Suppl):S61-8. doi: 10.1207/s15430154jce2101s_12. J Cancer Educ. 2006. PMID: 17020505 Review.
Cited by
-
Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.World J Gastroenterol. 2012 May 21;18(19):2423-9. doi: 10.3748/wjg.v18.i19.2423. World J Gastroenterol. 2012. PMID: 22654436 Free PMC article.
-
Ectopic expression of RASSF2 and its prognostic role for gastric adenocarcinoma patients.Exp Ther Med. 2012 Mar;3(3):391-396. doi: 10.3892/etm.2011.440. Epub 2011 Dec 28. Exp Ther Med. 2012. PMID: 22969901 Free PMC article.
-
Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x. Epub 2011 Nov 23. Pathol Oncol Res. 2012. PMID: 22109561
-
Lifetime risk for cancer death by sex and smoking status: the lifetime risk pooling project.Cancer Causes Control. 2012 Oct;23(10):1729-37. doi: 10.1007/s10552-012-9959-0. Epub 2012 Jul 24. Cancer Causes Control. 2012. PMID: 22825072 Free PMC article.
-
Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer.Int J Clin Exp Med. 2014 Apr 15;7(4):973-81. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 24955170 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources